Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BOM/543594 stock hub

BOM/543594 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/543594is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

215.6M

Bombay Stock Exchange

Market data

Price

Recent price action with selectable time range.

BOM/543594BOM/543594

—

Loading chart…

In the news

Latest news · BOM/543594

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E9.5

P25 n/aP50 n/aP75 n/a

ROE4.2

P25 n/aP50 n/aP75 n/a

ROIC3.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/543594 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 346.5M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 215.6M
Price	INR 8.2
Price currency	INR
Sic	5122
Symbol	bom/543594
Website	https://dipnapharmachem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.5%
EV Earnings	16.92x
EV/EBIT	8.78x
EV/EBITDA	8.75x
EV/FCF	-2.46x
EV/Sales	0.33x
FCF yield	-65.37%
P/B ratio	0.37x
P/E ratio	9.48x
P/S ratio	0.2x
PE Ratio10 Y	24.27x
PE Ratio3 Y	29.35x
PE Ratio5 Y	25.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.7%
EBITDA Margin	3.71%
Gross margin	16.87%
Gross Profit	INR 179.9M
Gross Profit Growth	61.03%
Gross Profit Growth Q	215.96%
Gross Profit Growth3 Y	41.13%
Gross Profit Growth5 Y	32.33%
Net Income	INR 20.5M
Net Income Growth	146.32%
Net Income Growth Q	319.07%
Net Income Growth3 Y	23.58%
Net Income Growth5 Y	17.57%
Pretax Margin	2.69%
Profit Margin	1.92%
ROA	1.59
Roa5y	2.39
ROCE	5.69
ROE	4.23
Roe5y	23.68
ROIC	3.91
Roic5y	6.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.65%
Cagr3y	-14.73%
EPS Growth	75.54
EPS Growth Q	321.4
EPS Growth3 Y	-1.33
EPS Growth5 Y	2.61
Revenue Growth	-41.07x
Revenue Growth Q	-20.19x
Revenue Growth3 Y	-13.43x
Revenue Growth5 Y	1.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.69
Assets	INR 1.8B
Cash	INR 6.9M
Current Assets	INR 1.8B
Current Liabilities	INR 1.1B
Debt	INR 137.9M
Debt EBITDA	INR 3.48
Debt Equity	INR 0.23
Debt FCF	INR -0.98
Equity	INR 588.9M
Interest Coverage	1.72
Liabilities	INR 1.2B
Long Term Assets	INR 504,000
Long Term Liabilities	INR 105.3M
Net Cash	INR -131M
Net Cash By Market Cap	INR -60.75
Net Debt EBITDA	INR 3.31
Net Debt Equity	INR 0.22
Tangible Book Value	INR 588.9M
Tangible Book Value Per Share	INR 24.62
WACC	6.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.64
Inventory Turnover	2.93
Net Working Capital	INR 719.3M
Quick ratio	0.53
Working Capital	INR 693.7M
Working Capital Turnover	INR 1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.62%
200-day SMA	16.62
3Y total return	-38.01%
50-day SMA	9.14
50-day SMA vs 200-day SMA	50under200
All Time High	33.6
All Time High Change	-75.6%
All Time High Date	2022-09-08
All Time Low	6.4
All Time Low Change	28.13%
All Time Low Date	2024-11-12
ATR	0.71
Beta	-0.15
Beta1y	0.9
Beta2y	0.63
Ch YTD	-51.48
High	8.2
High52	26.31
High52 Date	2025-05-19
High52ch	-68.83%
Low	7.67
Low52	7.25
Low52 Date	2026-04-28
Low52ch	13.1%
Ma50ch	-10.27%
Price vs 200-day SMA	-50.66%
RSI	43.17
RSI Monthly	36.31
RSI Weekly	31.62
Sharpe ratio	-0.35x
Sortino ratio	-0.39
Total Return	-40.32%
Tr YTD	-51.48
Tr1m	-8.89%
Tr1w	-2.38%
Tr3m	-35.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 39.5M
Operating Income Growth	5.91
Operating Income Growth Q	14.97
Operating Income Growth3 Y	4.82
Operating Income Growth5 Y	11.02
Operating margin	3.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,502,550%
Net Borrowing	-22,221,000
Shares Insiders	47.16%
Shares Out	26,289,250
Shares Qo Q	1.91%
Shares Yo Y	40.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -140.9M
Average Volume	64,050x
Bv Per Share	24.62
CAPEX	INR -270,000
Ch1m	-8.89
Ch1w	-2.38
Ch1y	-64.62
Ch3m	-35.48
Ch3y	-49.07
Ch6m	-58.79
Change	-1.32%
Change From Open	6.91
Close	8.31
Days Gap	-7.7
Depreciation Amortization	125,000
Dollar Volume	196,800
Earnings Date	2026-06-12
EBIT	INR 39.5M
EBITDA	INR 39.6M
EPS	INR 0.86
F Score	4
FCF	INR -140.9M
FCF EV Yield	-40.66x
FCF Per Share	INR -5.36
Financing CF	147,625,000
Fiscal Year End	March
Founded	2,011
Graham Number	21.88636
Graham Upside	163.4
Income Tax	INR 8.2M
Investing CF	-270,000
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-09-30
Lynch Fair Value	INR 15.19
Lynch Upside	82.8
Ma150	14.72
Ma150ch	-44.3%
Ma20	8.77
Ma20ch	-6.49%
Net CF	6,717,000
Next Earnings Date	2026-06-12
Open	7.67
Position In Range	100
Ppne	473,000
Price Date	2026-05-08
Price EBITDA	INR 5.44
Ptbv Ratio	0.37
Relative Volume	0.37x
Revenue	1,066,216,000x
Tax By Revenue	0.77x
Tax Rate	28.66%
Tr6m	-58.79%
Volume	24,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/543594 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/543594 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/543594?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+47.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+40.3%

Negative means the company is buying back shares.

Technical

BOM/543594 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.2

Neutral momentum band

Price vs 200-day MA

-50.7%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

-0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/543594

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/543594 stock rating?

bom/543594 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/543594 analysis?

The full report lives at /stocks/bom/543594/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/543594?

The latest report frames bom/543594 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/543594 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.